A third drug, pretomanid, received emergency authorization from the FDA for specific use within a regimen against highly drug ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected ...

Researchers reviewed previously published studies to understand trends in multidrug-resistant treatment of TB in children and ...

Evidence to date has been limited on MDR-TB preventive treatment since no randomised controlled trials had ever been conducted. "The VQUIN trial is a major step forward in the fight against drug ...

New options make TB treatment faster, safer, and more accessible. A major breakthrough in tuberculosis treatment has emerged: ...

A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

An estimated 400,000 people develop MDR-TB disease each year, which is complex to treat with current medications that have many side effects. The treatment is very costly for both families and ...

Tuberculosis remains one of the top infectious disease killers worldwide , a challenge amplified by drug-resistant forms of the disease. Now, in a ...

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

Panel asks govt to ensure consistent supply of drugs, scaling up testing facilities against TB: Gireesh Babu, New Delhi Monday, February 10, 2025, 08:00 Hrs [IST] A Parliamentary ...

If we truly want to prevent MDR-TB, we must arrest the spread. This can only be achieved by universal molecular diagnostics to detect drug-resistant TB at an early stage. Since a majority of ...